|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Dec 31, 2021
|
|
|---|---|---|
| Revenue | ||
| Platform | ||
| Transaction | ||
| Total revenue | ||
| Cost of revenue | ||
| Platform | ||
| Transaction | ||
| Depreciation and impairment | ||
| Total cost of revenue | ||
| Gross profit | ||
| Operating expenses: | ||
| Research and development | ||
| Sales and marketing | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Change in fair value of warrant liabilities | ||
| Loss on initial issuance of private warrants | ||
| Interest earned on marketable securities held in Trust Account | ||
| Total other income (expense), net | ||
| Change in fair value of warrants and convertible promissory notes | ||
| Interest expense | ||
| Other financing and financial instrument expenses, net | ||
| Other income, net | ||
| Total other income (expense), net | ||
| Loss before provision (benefit) for income taxes | ||
| Provision (benefit) for income taxes | ||
| Net loss and comprehensive loss | ||
| Basic and diluted weighted average shares outstanding of common stock (in Shares) | ||
| Basic and diluted net income (loss) per common share (in Dollars per share) | ||
| Net loss per share attributable to Common Stockholders, basic | ||
| Net loss per share attributable to Common Stockholders, diluted | ||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | ||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted |
Loading...
